Exidine and Vasculitis - a phase IV clinical study of FDA data

Summary:

Vasculitis is reported as a side effect among people who take Exidine (chlorhexidine gluconate), especially for people who are female, 60+ old, also take Cephalexin, and have Acute myeloid leukaemia.

The phase IV clinical study analyzes which people have Vasculitis when taking Exidine. It is created by eHealthMe based on reports of 17,245 people who have side effects when taking Exidine from the FDA, and is updated regularly.

What is Exidine?

Exidine has active ingredients of chlorhexidine gluconate. eHealthMe is studying from 17,299 Exidine users. Check the latest studies of Exidine.

What is Vasculitis?

Vasculitis (inflammation of a blood vessel or blood vessels) is found to be associated with 968 drugs and 1,214 conditions by eHealthMe. Check the latest studies of Vasculitis.

On Jul, 05, 2026

17,245 people reported to have side effects when taking Exidine.
Among them, 18 people (0.1%) have Vasculitis.

Among these 18 people:

What is the gender of people who have Vasculitis when taking Exidine? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Vasculitis when taking Exidine? *

What are other drugs people take besides Exidine? *

What are other side effects people have besides Vasculitis? *

Fever: 5 people, 27.78%
General Physical Health Deterioration (weak health status): 5 people, 27.78%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 27.78%
Thrombophlebitis (swelling (inflammation) of a vein caused by a blood clot): 5 people, 27.78%
Oedema Peripheral (superficial swelling): 4 people, 22.22%
Pain: 3 people, 16.67%
Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 16.67%
Emotional Distress: 3 people, 16.67%
Stress And Anxiety: 3 people, 16.67%
Osteonecrosis Of Jaw (death of bone of jaw): 3 people, 16.67%

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 4 people, 22.22%
Osteoporosis (bones weak and more likely to break): 2 people, 11.11%
Colon Cancer: 2 people, 11.11%
Behcet's Syndrome (involves inflammation of the blood vessels): 2 people, 11.11%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 5.56%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.56%
Prostate Cancer Metastatic: 1 person, 5.56%
Pancreatic Carcinoma (pancreatic cancer): 1 person, 5.56%
Hiv Infection: 1 person, 5.56%
Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant): 1 person, 5.56%

* Approximation only. Some reports may have incomplete information.

Do you take Exidine and have Vasculitis?

- Check whether Vasculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Exidine:

Exidine (17,299 reports)

Vasculitis treatments and more:

Vasculitis (18,555 reports)

Browse all side effects of Exidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Vasculitis:

Vasculitis (968 drugs)

Browse all the conditions that are associated with Vasculitis:

Vasculitis (1,214 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on chlorhexidine gluconate (the active ingredients of Exidine) and Exidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.